Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Rifkin

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Annual Review of Immunology|March 24, 2007
Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory diseaseAnn Marshak-Rothstein, Ian R Rifkin
Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2017
Editorial: Podocytes as Active Participants in Lupus NephritisIan R Rifkin, Ramon G Bonegio
Nature Immunology|June 28, 2003
T-bet: the Toll-bridge to class-switch recombination?Ian R Rifkin, Ann Marshak-Rothstein
Seminars in Nephrology|March 15, 2006
Lupus nephritisNeerja Agrawal, Lo-Ku Chiang, Ian R Rifkin
Current Directions in Autoimmunity|November 1, 2002
Toll-like receptors and activation of autoreactive B cellsElizabeth A Leadbetter, Ian R Rifkin, Ann Marshak-Rothstein
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosusAmanda A Watkins, Ramon G B Bonegio, Ian R Rifkin
Rheumatic Diseases Clinics of North America|July 21, 2004
The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunityAnn Marshak-Rothstein, Liliana Busconi, Ian R Rifkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2023
Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic PathwaysAlex Pellerin, Ying Tan, Simon Lu, et al.
Immunological Reviews|March 26, 2005
Toll-like receptors, endogenous ligands, and systemic autoimmune diseaseIan R Rifkin, Elizabeth A Leadbetter, Liliana Busconi, et al.
Immunology|January 25, 2014
Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosusTamar R Aprahamian, Ramon G Bonegio, Zachary Weitzner, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Annual Review of Immunology|March 24, 2007
Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory diseaseAnn Marshak-Rothstein, Ian R Rifkin
Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2017
Editorial: Podocytes as Active Participants in Lupus NephritisIan R Rifkin, Ramon G Bonegio
Nature Immunology|June 28, 2003
T-bet: the Toll-bridge to class-switch recombination?Ian R Rifkin, Ann Marshak-Rothstein
Seminars in Nephrology|March 15, 2006
Lupus nephritisNeerja Agrawal, Lo-Ku Chiang, Ian R Rifkin
Current Directions in Autoimmunity|November 1, 2002
Toll-like receptors and activation of autoreactive B cellsElizabeth A Leadbetter, Ian R Rifkin, Ann Marshak-Rothstein
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosusAmanda A Watkins, Ramon G B Bonegio, Ian R Rifkin
Rheumatic Diseases Clinics of North America|July 21, 2004
The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunityAnn Marshak-Rothstein, Liliana Busconi, Ian R Rifkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2023
Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic PathwaysAlex Pellerin, Ying Tan, Simon Lu, et al.
Immunological Reviews|March 26, 2005
Toll-like receptors, endogenous ligands, and systemic autoimmune diseaseIan R Rifkin, Elizabeth A Leadbetter, Liliana Busconi, et al.
Immunology|January 25, 2014
Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosusTamar R Aprahamian, Ramon G Bonegio, Zachary Weitzner, et al.
Pageof 5